Home › Pheochromocytoma › Pennsylvania › Philadelphia
Pheochromocytoma clinical trials in Philadelphia, PA
3 studies for Pheochromocytoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- and 1 more
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Recruiting
- Penn Medicine, Philadelphia
In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
RecruitingEarly phase 1
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
About Pheochromocytoma
Pheochromocytoma is a rare tumor. Pheochromocytomas often cause the adrenal gland to make too many hormones. This can lead to high blood pressure.
More about Pheochromocytoma on MedlinePlus
Pheochromocytoma trials in other cities
- Washington, DC9 studies
- Chicago, IL3 studies
- Nashville, TN3 studies
- Los Angeles, CA3 studies
- Cedar Rapids, IA3 studies
- Baltimore, MD3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.